EXCLUSIVE: Nvidia's Biggest Contribution to AI Drug Discovery Isn't Money, Generate CTO Says
Generate Biomedicines co-founder & CTO says Nvidia's biggest contribution to AI drug discovery is technical collaboration, not just capital.
Nvidia is helping a drug-discovery company get better at using AI by working closely with them on the technical side, not just giving them money. This shows Nvidia's technology is valuable and trusted by companies trying to solve hard problems.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.